“If ALL18 POCT antibody suppliers were able to provide 12000 tests each”
As you know, these tests come in packs of 20 and are not sold separately, in the same way that Panadol might be sold in packs of 24, you don’t just buy one.
The question still remains then, does CDY have 12,000 tests which is only 600 packs at a wholesale cost of approximately $60,000, or do they have 12,000 packs of 20 at an estimated cost of $1.2M? After all they did raise $6m.
If it is the former as you say and all these suppliers just sell 12,000 tests then that’s only $60k stock each at cost based on my estimate.
Hardly worth the effort from a business point of view.
I thought CDY had exclusitivity, but doesn’t appear to be the case.
For the record I have been a holder of CDY going back several years. I don’t currently hold stock but have traded a few during this current rally.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-281
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable